Toxicogenomics of Hepatotoxicity in Monkeys

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$249,123.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R44DK066955-01
Agency Tracking Number:
DK066955
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
RXGEN, INC.
100 DEEPWOOD DRIVE, HAMDEN, CT, 06517
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
MATTHEW Lawrence
(203) 498-9706
MLAWRENCE@RX-GEN.COM
Business Contact:
(203) 498-9706
HPENNER@RX-GEN.COM
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant): SBIR Phase I Research: This proposal aims to examine the predictive utility of an in vivo primate toxicogenomic model of human hepatotoxicity. Hepatotoxicity is the most significant and common adverse drug reacti

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government